Systematic Review of Endovascular, Surgical, and Conservative Options for Infectious Intracranial Aneurysms and Cardiac Considerations

2019 ◽  
Vol 28 (3) ◽  
pp. 838-844 ◽  
Author(s):  
Ranjan Ragulojan ◽  
Stephen Grupke ◽  
Justin F. Fraser
2020 ◽  
Vol 144 ◽  
pp. 293-298.e15
Author(s):  
Bhargav Desai ◽  
Sauson Soldozy ◽  
Harshal Desai ◽  
Jeyan Kumar ◽  
Smit Shah ◽  
...  

2018 ◽  
Vol 10 (7) ◽  
pp. 708-716 ◽  
Author(s):  
Ali Alawieh ◽  
M Imran Chaudry ◽  
Raymond D Turner ◽  
Aquilla S Turk ◽  
Alejandro M Spiotta

Infectious intracranial aneurysms (IIAs) are a rare cerebrovascular complication of systemic infections induced by microbial infiltration and degradation of the arterial vessel wall. Studies on the epidemiology and management of IIAs are limited to case reports and retrospective single-center studies, and report a large variability in epidemiological features, management, and outcomes due to the limited sample size. We conducted a systematic review of all published papers on IIAs in the English literature using MEDLINE and SCOPUS database from January 1950 to June 2017. A total of 288 publications describing 1191 patients with IIA (1398 aneurysms) were included and reviewed for epidemiological features, disease features, treatment and outcome. All patients were merged into a single cohort and summary data are presented. The majority of reported IIAs are distally located, relatively small (<5 mm), involve the anterior circulation, are associated with a relatively high rate of rupture, and demonstrate a propensity to multiplicity of aneurysms. Sensitive diagnosis of IIAs requires digital subtraction angiography and not CT angiography or MR angiography. Treatment of ruptured, symptomatic, or enlarging IIAs has evolved over the last 50 years. Endovascular therapy is associated with a high success rate and low morbidity compared with microsurgical and medical management. A treatment algorithm for the management of patients with IIA in various contexts is proposed and the need for prospective multicenter studies is emphasized.


2018 ◽  
Author(s):  
Alexander F. Hulsbergen ◽  
Lida Mirzaei ◽  
Arthur T. Van der Boog ◽  
Timothy R. Smith ◽  
Ivo S. Muskens ◽  
...  

2013 ◽  
Vol 6 (5) ◽  
pp. 353-356 ◽  
Author(s):  
Ramesh Grandhi ◽  
Nathan T Zwagerman ◽  
Guillermo Linares ◽  
Edward A Monaco ◽  
Tudor Jovin ◽  
...  

2014 ◽  
Vol 1 (3) ◽  
pp. 220-232 ◽  
Author(s):  
Michael J. Bonares ◽  
A. Leonardo de Oliveira Manoel ◽  
R. Loch Macdonald ◽  
Tom A. Schweizer

2021 ◽  
pp. 159101992110279
Author(s):  
Muhammad Waqas ◽  
Rimal H Dossani ◽  
Modhi Alkhaldi ◽  
Jocelyn Neveu ◽  
Justin M Cappuzzo ◽  
...  

Introduction The Flow Redirection Endoluminal Device (FRED; MicroVention) is a dual-layered flow diverter used for the treatment of intracranial aneurysms. The objective of this systematic review was to compile device-related safety and effectiveness data. Methods The literature from January 1, 2013 to April 30, 2021 was searched for studies describing use of the FRED for intracranial aneurysm treatment irrespective of aneurysm location and morphology. The review included anterior and posterior circulation ruptured and unruptured saccular, fusiform or dissection, and blister aneurysms. MeSH terms related to “flow re-direction endoluminal device” and “FRED for aneurysms” were used. Data related to indication, complications, and rates of aneurysm occlusion were retrieved and analyzed. Results Twenty-two studies with 1729 intracranial aneurysms were included in this review. Overall reported morbidity was 3.9% (range 0–20%). Overall procedure-related mortality was 1.4% (range 0–6%). Complication rates fell into 5 categories: technical (3.6%), ischemic (3.8%), thrombotic or stenotic (6%), hemorrhagic (1.5%), and non-neurological (0.8%). The aneurysm occlusion rate between 0 and 3 months (reported in 11 studies) was 47.8%. The occlusion rate between 4 and 6 months (reported in 14 studies) was 73.8%. Occlusion rates continued to increase to 75.1% at 7–12 months (reported in 10 studies) and 86.6% for follow-up beyond 1 year (reported in 10 studies). Conclusion This review indicated that the FRED is a safe and effective for the treatment of intracranial aneurysms. Future studies should directly compare the FRED with other flow diverters for a better understanding of comparative safety and effectiveness among the different devices.


2017 ◽  
Vol 11 (10) ◽  
pp. 497-503
Author(s):  
Hajime Nakamura ◽  
Toshiyuki Fujinaka ◽  
Takeo Nishida ◽  
Tomohiko Ozaki ◽  
Katsunori Asai ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document